Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clelia Dallanoce

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|March 15, 2006
Synthesis of enantiopure Delta2-isoxazoline derivatives and evaluation of their affinity and efficacy profiles at human beta-adrenergic receptor subtypesClelia Dallanoce, Giuseppe Meroni, Marco De Amici, et al.
Bioorganic & Medicinal Chemistry|February 17, 2007
Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypesClelia Dallanoce, Fabio Frigerio, Marco De Amici, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding CorrelationMarco Maspero, Xia Cheng, Valeska von Kiedrowski, et al.
European Journal of Pharmacology|December 25, 2017
In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ<sup>2</sup>-isoxazoline molecular skeletonCarlo Matera, Giulio Dondio, Daniela Braida, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2012
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring systemClelia Dallanoce, Carlo Matera, Luca Pucci, et al.
Cells|July 11, 2025
Effects of Selective α7 Nicotinic Acetylcholine Receptor Stimulation in Oligodendrocytes: Putative Implication in NeuroinflammationClaudia Guerriero, Giulia Puliatti, Tamara Di Marino, et al.
Bioorganic & Medicinal Chemistry|October 2, 2012
A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptakeClelia Dallanoce, Mara Canovi, Carlo Matera, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 10, 2020
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activityEttore Gilardoni, Silvia Gervasoni, Marco Maspero, et al.
European Journal of Pharmacology|May 18, 2021
Stable desensitization of α<sub>7</sub> nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding siteMaria Chiara Pismataro, Nicole A Horenstein, Clare Stokes, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypesLuca Rizzi, Clelia Dallanoce, Carlo Matera, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|March 15, 2006
Synthesis of enantiopure Delta2-isoxazoline derivatives and evaluation of their affinity and efficacy profiles at human beta-adrenergic receptor subtypesClelia Dallanoce, Giuseppe Meroni, Marco De Amici, et al.
Bioorganic & Medicinal Chemistry|February 17, 2007
Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypesClelia Dallanoce, Fabio Frigerio, Marco De Amici, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding CorrelationMarco Maspero, Xia Cheng, Valeska von Kiedrowski, et al.
European Journal of Pharmacology|December 25, 2017
In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ<sup>2</sup>-isoxazoline molecular skeletonCarlo Matera, Giulio Dondio, Daniela Braida, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2012
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring systemClelia Dallanoce, Carlo Matera, Luca Pucci, et al.
Cells|July 11, 2025
Effects of Selective α7 Nicotinic Acetylcholine Receptor Stimulation in Oligodendrocytes: Putative Implication in NeuroinflammationClaudia Guerriero, Giulia Puliatti, Tamara Di Marino, et al.
Bioorganic & Medicinal Chemistry|October 2, 2012
A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptakeClelia Dallanoce, Mara Canovi, Carlo Matera, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 10, 2020
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activityEttore Gilardoni, Silvia Gervasoni, Marco Maspero, et al.
European Journal of Pharmacology|May 18, 2021
Stable desensitization of α<sub>7</sub> nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding siteMaria Chiara Pismataro, Nicole A Horenstein, Clare Stokes, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypesLuca Rizzi, Clelia Dallanoce, Carlo Matera, et al.
Pageof 7